Rhabdomyosarcoma Embryonal - 11 Studies Found
Recruiting |
: Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma :
|
Recruiting |
: Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma : Sarcoma : 2005-10-25 :
|
Recruiting |
: Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma : Sarcoma : 2005-10-25 :
|
Active, not recruiting |
: Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma :
|
Suspended |
: Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma :
|
Active, not recruiting |
: Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma :
|
Completed |
: Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma :
: |
Completed |
: Biomarkers in Patients With Advanced Rhabdomyosarcoma :
: Other: Laboratory Biomarker Analysis Correlative studies |
Completed |
: Collecting Tumor Samples From Patients With Gynecological Tumors :
|